Search

Your search keyword '"Choudhri, Shurjeel H."' showing total 19 results
Start Over Author "Choudhri, Shurjeel H."
19 results on '"Choudhri, Shurjeel H."'

8. Community-acquired pneumonia recovery in the elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy

Author

Anzueto, Antonio, Niederman, Michael S., Pearle, James, Restrepo, Marcos I., Heyder, Albrecht, and Choudhri, Shurjeel H.

Subjects
Bacterial pneumonia -- Risk factors, Bacterial pneumonia -- Diagnosis, Bacterial pneumonia -- Drug therapy, Pneumonia -- Risk factors, Pneumonia -- Diagnosis, Pneumonia -- Drug therapy, Aged patients -- Health aspects, Health, Health care industry
Published
2006

12. Diagnosis

Author

Wiseman, Marni C, Embil, John M, Choudhri, Shurjeel H, and University of Manitoba

Subjects
Microbiology (medical), Clinical Vignette, lcsh:RC109-216, lcsh:Infectious and parasitic diseases
Published
1998
Full Text
View/download PDF

14. Community Intravenous Therapy Program and a Treatment Plan for Foot Infections in Persons with Diabetes: A Clinical Perspective

Author

Embil, John M, primary, Choudhri, Shurjeel H, additional, Germaine, Glenna, additional, Imlah, Theresa, additional, Duerksen, Frank, additional, Darcel, Marie, additional, Fong, Hank, additional, Koulack, Joshua, additional, Gin, Alfred, additional, Stern, Sheryl, additional, Simonsen, J Neil, additional, Harding, Godfrey KM, additional, and Nicolle, Lindsay E, additional

Published
2000
Full Text
View/download PDF

19. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.

Author

Miravitlles M, Kruesmann F, Haverstock D, Perroncel R, Choudhri SH, and Arvis P

Subjects
Anti-Bacterial Agents therapeutic use, Aza Compounds therapeutic use, Bacteria drug effects, Bacteria isolation & purification, Bronchitis, Chronic drug therapy, Color, Dyspnea drug therapy, Dyspnea microbiology, Female, Fluoroquinolones, Gentian Violet, Humans, Male, Moxifloxacin, Multicenter Studies as Topic, Phenazines, Pneumonia, Bacterial drug therapy, Pneumonia, Bacterial microbiology, Quinolines therapeutic use, Randomized Controlled Trials as Topic, Sex Factors, Sputum drug effects, Bronchitis, Chronic microbiology, Disease Progression, Sputum microbiology
Abstract

We examined the correlation between sputum colour and the presence of potentially pathogenic bacteria in acute exacerbations of chronic bronchitis (AECBs). Data were pooled from six multicentre studies comparing moxifloxacin with other antimicrobials in patients with an AECB. Sputum was collected before antimicrobial therapy, and bacteria were identified by culture and Gram staining. Association between sputum colour and bacteria was determined using logistic regression. Of 4,089 sputum samples, a colour was reported in 4,003; 1,898 (46.4%) were culture-positive. Green or yellow sputum samples were most likely to yield bacteria (58.9% and 45.5% of samples, respectively), compared with 18% of clear and 39% of rust-coloured samples positive for potentially pathogenic microorganisms. Factors predicting a positive culture were sputum colour (the strongest predictor), sputum purulence, increased dyspnoea, male sex and absence of fever. Green or yellow versus white sputum colour was associated with a sensitivity of 94.7% and a specificity of 15% for the presence of bacteria. Sputum colour, particularly green and yellow, was a stronger predictor of potentially pathogenic bacteria than sputum purulence and increased dyspnoea in AECB patients. However, it does not necessarily predict the need for antibiotic treatment in all patients with AECB.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results